Royal Bank Of Canada Has Lowered Expectations for Moderna (NASDAQ:MRNA) Stock Price

Moderna ( NASDAQ:MRNA – Get Free Report ) had its price objective reduced by stock analysts at Royal Bank Of Canada from $28.00 to $25.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has a “sector perform
Read more...